Dr. Peter Andrew Bleszynski, MD

Dr. Bleszynski practices at North Vista Hospital in North Las Vegas, Nevada, part of Prime Healthcare Services.

Dr. Bleszynski's NPI, 1831577584, was assigned on May 14, 2015. Dr. Bleszynski holds Nevada license 22158.

Dr. Bleszynski's primary practice is North Vista Hospital, at 1409 East Lake Mead Blvd, North Las Vegas, NV 89030 in Clark County. The practice phone is (702) 649-7711.

Dr. Bleszynski's primary practice is North Vista Hospital in North Las Vegas, Nevada, part of Prime Healthcare Services. Dr. Bleszynski is also affiliated with MountainView Hospital. The medical group on file is Prime Cardiology Group. Dmand AI also links Dr. Bleszynski to 3 more hospitals, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bleszynski practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bleszynski's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bleszynski is licensed in Nevada.

CMS data shows 1,868 Medicare services from Dr. Bleszynski across 29 procedure codes in 2024, for 625 Medicare patients. Medicare paid $189,961 for them.

CMS counts 625 Medicare patients who saw Dr. Bleszynski in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bleszynski's median patient age at 73, with 50% women.

In 2024, Dr. Bleszynski wrote 935 Medicare Part D claims for 205 patients. 84% of them were for generic drugs. CMS names the drug for 716 of them, across 15 drugs with 11 or more claims each, at $114,479 in total drug cost. In 2023, CMS named 159 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Bleszynski for performance year 2024, reported as part of a group. Dr. Bleszynski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of coronary angioplasty and stenting by Dr. Bleszynski, more than 80% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Bleszynski, published from 2020 to 2021. Dr. Bleszynski's most frequent co-authors are Mehmet K. Aktas, MD, Jeffrey T. Bruckel, MD and Genaro Fernandez, MD.

CMS Open Payments shows 236 general payments to Dr. Bleszynski from 36 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 97% of the total. Abiomed paid the most, $2,254. It also lists 1 research payment totaling $124 in 2023.